An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica

Abstract The aim of the study was to investigate the presence of subclinical vascular damage in polymyalgia rheumatica (PMR). We enrolled PMR patients having major cardiovascular risk factors (MCVRF) and, as controls, patients with MCVRF. All underwent: color Doppler ultrasound to evaluate the commo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rossana Scrivo, Valeria Silvestri, Francesco Ciciarello, Paola Sessa, Iolanda Rutigliano, Cristina Sestili, Giuseppe La Torre, Cristiana Barbati, Alessio Altobelli, Cristiano Alessandri, Fulvia Ceccarelli, Manuela Di Franco, Roberta Priori, Valeria Riccieri, Antonio Sili Scavalli, Francesca Romana Spinelli, Luciano Agati, Francesco Fedele, Bruno Gossetti, Fabrizio Conti, Guido Valesini
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6b92784b7b974a7ebaf8c14217a496df
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6b92784b7b974a7ebaf8c14217a496df
record_format dspace
spelling oai:doaj.org-article:6b92784b7b974a7ebaf8c14217a496df2021-12-02T15:39:48ZAn exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica10.1038/s41598-020-68215-82045-2322https://doaj.org/article/6b92784b7b974a7ebaf8c14217a496df2020-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-68215-8https://doaj.org/toc/2045-2322Abstract The aim of the study was to investigate the presence of subclinical vascular damage in polymyalgia rheumatica (PMR). We enrolled PMR patients having major cardiovascular risk factors (MCVRF) and, as controls, patients with MCVRF. All underwent: color Doppler ultrasound to evaluate the common carotid intima-media thickness (IMT), the anterior–posterior abdominal aortic diameter (APAD), and the prevalence of carotid artery stenosis; the cardio-ankle vascular index (CAVI) to measure arterial stiffness together with the ankle-brachial index (ABI) to investigate the presence of lower-extremity peripheral arterial disease. Finally, we measured the serum levels of adipocytokines implicated in vascular dysfunction. As a result, 48 PMR and 56 MCVRF patients were included. An increase of IMT (1.07/0.8–1.2 vs 0.8/0.8–1.05; p = 0.0001), CAVI (8.7/7.8–9.3 vs 7.6/6.9–7.8; p < 0.0001) and APAD values (21.15/18.1–25.6 vs 18/16–22; p = 0.0013) was found in PMR patients with respect to controls. No differences were reported in the prevalence of carotid artery stenosis or ABI values between the two groups. A significant correlation between IMT and CAVI in PMR and MCVRF subjects (r2 = 0.845 and r2 = 0.556, respectively; p < 0.01) was found. Leptin levels (pg/mL; median/25th–75th percentile) were higher in PMR than in MCVRF subjects (145.1/67–398.6 vs 59.5/39.3–194.3; p = 0.04). Serum levels of adiponectin (ng/mL) were higher in PMR patients (15.9/10.65–24.1 vs 6.1/2.8–22.7; p = 0.01), while no difference in serum levels of resistin (ng/mL) was found between PMR and MCVRF subjects (0.37/0.16–0.66 vs 0.26/0.14–1.24). Our study shows an increased subclinical vascular damage in PMR patients compared to those with MCVRF, paving the way for further studies aimed at planning primary cardiovascular prevention in this population.Rossana ScrivoValeria SilvestriFrancesco CiciarelloPaola SessaIolanda RutiglianoCristina SestiliGiuseppe La TorreCristiana BarbatiAlessio AltobelliCristiano AlessandriFulvia CeccarelliManuela Di FrancoRoberta PrioriValeria RiccieriAntonio Sili ScavalliFrancesca Romana SpinelliLuciano AgatiFrancesco FedeleBruno GossettiFabrizio ContiGuido ValesiniNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Rossana Scrivo
Valeria Silvestri
Francesco Ciciarello
Paola Sessa
Iolanda Rutigliano
Cristina Sestili
Giuseppe La Torre
Cristiana Barbati
Alessio Altobelli
Cristiano Alessandri
Fulvia Ceccarelli
Manuela Di Franco
Roberta Priori
Valeria Riccieri
Antonio Sili Scavalli
Francesca Romana Spinelli
Luciano Agati
Francesco Fedele
Bruno Gossetti
Fabrizio Conti
Guido Valesini
An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica
description Abstract The aim of the study was to investigate the presence of subclinical vascular damage in polymyalgia rheumatica (PMR). We enrolled PMR patients having major cardiovascular risk factors (MCVRF) and, as controls, patients with MCVRF. All underwent: color Doppler ultrasound to evaluate the common carotid intima-media thickness (IMT), the anterior–posterior abdominal aortic diameter (APAD), and the prevalence of carotid artery stenosis; the cardio-ankle vascular index (CAVI) to measure arterial stiffness together with the ankle-brachial index (ABI) to investigate the presence of lower-extremity peripheral arterial disease. Finally, we measured the serum levels of adipocytokines implicated in vascular dysfunction. As a result, 48 PMR and 56 MCVRF patients were included. An increase of IMT (1.07/0.8–1.2 vs 0.8/0.8–1.05; p = 0.0001), CAVI (8.7/7.8–9.3 vs 7.6/6.9–7.8; p < 0.0001) and APAD values (21.15/18.1–25.6 vs 18/16–22; p = 0.0013) was found in PMR patients with respect to controls. No differences were reported in the prevalence of carotid artery stenosis or ABI values between the two groups. A significant correlation between IMT and CAVI in PMR and MCVRF subjects (r2 = 0.845 and r2 = 0.556, respectively; p < 0.01) was found. Leptin levels (pg/mL; median/25th–75th percentile) were higher in PMR than in MCVRF subjects (145.1/67–398.6 vs 59.5/39.3–194.3; p = 0.04). Serum levels of adiponectin (ng/mL) were higher in PMR patients (15.9/10.65–24.1 vs 6.1/2.8–22.7; p = 0.01), while no difference in serum levels of resistin (ng/mL) was found between PMR and MCVRF subjects (0.37/0.16–0.66 vs 0.26/0.14–1.24). Our study shows an increased subclinical vascular damage in PMR patients compared to those with MCVRF, paving the way for further studies aimed at planning primary cardiovascular prevention in this population.
format article
author Rossana Scrivo
Valeria Silvestri
Francesco Ciciarello
Paola Sessa
Iolanda Rutigliano
Cristina Sestili
Giuseppe La Torre
Cristiana Barbati
Alessio Altobelli
Cristiano Alessandri
Fulvia Ceccarelli
Manuela Di Franco
Roberta Priori
Valeria Riccieri
Antonio Sili Scavalli
Francesca Romana Spinelli
Luciano Agati
Francesco Fedele
Bruno Gossetti
Fabrizio Conti
Guido Valesini
author_facet Rossana Scrivo
Valeria Silvestri
Francesco Ciciarello
Paola Sessa
Iolanda Rutigliano
Cristina Sestili
Giuseppe La Torre
Cristiana Barbati
Alessio Altobelli
Cristiano Alessandri
Fulvia Ceccarelli
Manuela Di Franco
Roberta Priori
Valeria Riccieri
Antonio Sili Scavalli
Francesca Romana Spinelli
Luciano Agati
Francesco Fedele
Bruno Gossetti
Fabrizio Conti
Guido Valesini
author_sort Rossana Scrivo
title An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica
title_short An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica
title_full An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica
title_fullStr An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica
title_full_unstemmed An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica
title_sort exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/6b92784b7b974a7ebaf8c14217a496df
work_keys_str_mv AT rossanascrivo anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT valeriasilvestri anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT francescociciarello anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT paolasessa anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT iolandarutigliano anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT cristinasestili anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT giuseppelatorre anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT cristianabarbati anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT alessioaltobelli anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT cristianoalessandri anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT fulviaceccarelli anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT manueladifranco anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT robertapriori anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT valeriariccieri anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT antoniosiliscavalli anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT francescaromanaspinelli anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT lucianoagati anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT francescofedele anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT brunogossetti anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT fabrizioconti anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT guidovalesini anexploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT rossanascrivo exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT valeriasilvestri exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT francescociciarello exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT paolasessa exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT iolandarutigliano exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT cristinasestili exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT giuseppelatorre exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT cristianabarbati exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT alessioaltobelli exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT cristianoalessandri exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT fulviaceccarelli exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT manueladifranco exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT robertapriori exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT valeriariccieri exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT antoniosiliscavalli exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT francescaromanaspinelli exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT lucianoagati exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT francescofedele exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT brunogossetti exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT fabrizioconti exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
AT guidovalesini exploratorycrosssectionalstudyofsubclinicalvasculardamageinpatientswithpolymyalgiarheumatica
_version_ 1718385878447947776